Gilead Sciences reported $583M in Trade Creditors for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
ALKERMES ALKS:US 40.05M 12.35M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Amgen AMGN:US $ 1256M 147M
Biogen BIIB:US $ 434.8M 36.1M
Bluebird Bio BLUE:US $ 24.86M 3.48M
Bristol Myers Squibb BMY:US $ 2882M 62M
Coherus Biosciences CHRS:US $ 17.49M 3.61M
Eli Lilly And LLY:US $ 1659.3M 226M
Intercept Pharmaceuticals ICPT:US $ 11.67M 1.28M
Moderna Inc MRNA:US 181M 18M
Novartis NOVN:VX 4.97B 114M
Ptc Therapeutics PTCT:US $ 22.88M 4.52M
Puma Biotechnology PBYI:US $ 9.84M 2.43M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Sangamo Biosciences SGMO:US 13.08M 1.93M
Sarepta Therapeutics SRPT:US $ 56.21M 2.2M
Teva Pharmaceutical Industries TEVA:US $ 1901M 151M
Vertex Pharmaceuticals VRTX:US $ 198M 24.4M
YTE INCY:US $ 194.77M 42.22M